da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 3, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

November 30, 2028

Conditions
Colorectal CancerBenign or Malignant Rectal or Colon Tumors
Interventions
DEVICE

Robotic Assisted Surgery

da Vinci SP Surgical System, instruments, and accessories in complex colorectal procedures such as low anterior resection procedure or right colectomy with or without total mesorectal excision

Trial Locations (9)

15212

Allegheny General Hospital, Pittsburgh

32803

Adventist Health System/Sunbelt, Orlando

48202

Henry Ford, Detroit

55905

Mayo Clinic, Rochester

77030

Houston Methodist Research Institute, Houston

89128

MountianView Hospital, Las Vegas

98405

MultiCare - Tacoma, Tacoma

25 Daehakbyeongwon-ro

Ulsan University Hospital, Ulsan

Gonghang-daero

Ewha Womans University College of Medicine, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Intuitive Surgical

INDUSTRY

NCT04403022 - da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures | Biotech Hunter | Biotech Hunter